Filters

William K Oh, Philip W Kantoff, Vivian Weinberg, Graham Jones, Brian I Rini, Mika K Derynck, Robert Bok, Matthew R Smith, Glenn J Bubley, Robert T Rosen, Robert S DiPaola, Eric J Small

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(18):3705-12

Full Text

Abstract

Results: 1 – 15 / 15

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Estradiol Congeners""[mesh_terms]

Effects of oestrogen replacement therapy on pattern reversal visual evoked potentials.

Advanced oxidative processes and membrane separation for micropollutant removal from biotreated domestic wastewater.

Epigenetic markers of early tumor development.

Effect of estrogens on skin aging and the potential role of selective estrogen receptor modulators.

The effects of estrogen administration on bone mineral density in adolescents with anorexia nervosa.

Pentagastrin-induced release of free fatty acids in healthy volunteers and patients with panic disorder: effect of pretreatment with ethinyl estradiol.

Simulations of the estrogen receptor ligand-binding domain: affinity of natural ligands and xenoestrogens.

Bone mineral density in young, hypothalamic oligoamenorrheic women treated with oral contraceptives.

Effect of teriparatide [rhPTH(1-34)] on BMD when given to postmenopausal women receiving hormone replacement therapy.

Online solid phase extraction with liquid chromatography-tandem mass spectrometry for determination of estrogens and glucocorticoids in water.

Estrogen is associated with improved survival in aging women with congestive heart failure: analysis of the vesnarinone studies.

Esterified estrogen therapy in postmenopausal women. Relationships of bone marker changes and plasma estradiol to BMD changes: a two-year study.

Liver dysfunction in Turner's syndrome: prevalence, natural history and effect of exogenous oestrogen.

Contraception in diabetic women: comparative metabolic study of Norplant, depot medroxyprogesterone acetate, low dose oral contraceptive pill and CuT380A.

Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer.

Results for
""Estradiol Congeners""[mesh_terms]